Search Results - "Bonifazi, Francesca"

Refine Results
  1. 1
  2. 2
  3. 3

    Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation by Bonifazi, Francesca, Barbato, Francesco, Ravaioli, Federico, Sessa, Mariarosaria, Defrancesco, Irene, Arpinati, Mario, Cavo, Michele, Colecchia, Antonio

    Published in Frontiers in immunology (03-04-2020)
    “…Hepatic veno-occlusive disease (VOD) or sinusoidal obstruction syndrome (SOS) is a rare complication characterized by hepatomegaly, right-upper quadrant pain,…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia by Baccarani, Michele, Bonifazi, Francesca, Soverini, Simona, Castagnetti, Fausto, Gugliotta, Gabriele, Saber, Wael, Estrada-Merly, Noel, Rosti, Gianantonio, Gale, Robert Peter

    Published in Leukemia (01-05-2022)
    “…In this provocative commentary, we consider several questions posed by the late chronic myeloid leukaemia (CML) expert Prof. Michele Baccarani, which he…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Meibomian Gland Dropout in Hematological Patients Before Hematopoietic Stem Cell Transplantation by Giannaccare, Giuseppe, Bonifazi, Francesca, Sebastiani, Stefano, Sessa, Mariarosaria, Pellegrini, Marco, Arpinati, Mario, Moscardelli, Fabiana, Versura, Piera, Campos, Emilio

    Published in Cornea (01-10-2018)
    “…PURPOSE:To perform qualitative and quantitative analysis of meibomian gland (MG) dropout in hematological patients before hematopoietic stem cell…”
    Get full text
    Journal Article
  10. 10

    Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study by Cavallo, Maria Caterina, Cavazza, Marianna, Bonifazi, Francesca, Casadei, Beatrice, Cutini, Ilaria, Tonietti, Barbara, Saccardi, Riccardo, Zinzani, PierLuigi, Jommi, Claudio

    Published in BMC health services research (22-01-2024)
    “…Chimeric antigen receptor T cells (CAR-T) represent an innovation but raise issues for healthcare payers because of the uncertainty on impact at market launch,…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) by Snowden, John A., Saccardi, Riccardo, Orchard, Kim, Ljungman, Per, Duarte, Rafael F., Labopin, Myriam, McGrath, Eoin, Brook, Nigel, de Elvira, Carmen Ruiz, Gordon, Debra, Poirel, Hélène A., Ayuk, Francis, Beguin, Yves, Bonifazi, Francesca, Gratwohl, Alois, Milpied, Noel, Moore, John, Passweg, Jakob, Rizzo, J. Douglas, Spellman, Stephen R., Sierra, Jorge, Solano, Carlos, Sanchez-Guijo, Fermin, Worel, Nina, Gusi, Andreu, Adams, Gillian, Balan, Theodor, Baldomero, Helen, Macq, Gilles, Marry, Evelyne, Mesnil, Florence, Oldani, Elena, Pearce, Rachel, Perry, Julia, Raus, Nicole, Schanz, Urs, Tran, Steven, Wilcox, Leonie, Basak, Grzegorz W., Chabannon, Christian, Corbacioglu, Selim, Dolstra, Harry, Kuball, Jürgen, Mohty, Mohamad, Lankester, Arjan, Montoto, Sylvia, Nagler, Arnon, Styczynski, Jan, Yakoub-Agha, Ibrahim, de Latour, Regis Peffault, Kroeger, Nicolaus, Brand, Ronald, de Wreede, Liesbeth C., van Zwet, Erik, Putter, Hein

    Published in Bone marrow transplantation (Basingstoke) (01-04-2020)
    “…In many healthcare settings, benchmarking for complex procedures has become a mandatory requirement by competent authorities, regulators, payers and patients…”
    Get full text
    Journal Article Web Resource
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20